Fellow

Paula Williamson is Professor of Medical Statistics at the University of Liverpool. She is an international leader in clinical trials methodology and statistics and has led global initiatives in health technology assessment, which have had international impact on clinical practice. Her work on Cochrane individual patient data reviews of anti-epileptic drugs set the international methodological standard. She has developed methods for design and analysis of AED trials, including competing risks analysis of the Standard and New Antiepileptic Drugs trial. This trial has transformed the treatment of patients with epilepsy, underpinning UK, US and German clinical guidance, and influencing worldwide prescribing practice.